Argent Trust’s Quest Diagnostics DGX Stock Holding History

Argent Trust’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$2.5M	Sell	24,923 -30	-0.1%	-$3.07K	0.68%	45
2017 Q4	$2.46M	Sell	24,953 -50	-0.2%	-$4.74K	0.66%	46
2017 Q3	$2.34M	Hold	25,003	–	–	0.64%	50
2017 Q2	$2.78M	Sell	25,003 -199	-0.8%	-$21K	0.78%	38
2017 Q1	$2.48M	Sell	25,202 -400	-2%	-$38.1K	0.7%	40
2016 Q4	$2.35M	Sell	25,602 -5	-0%	-$431	0.68%	44
2016 Q3	$2.17M	Sell	25,607 -710	-3%	-$59.6K	0.66%	45
2016 Q2	$2.14M	Hold	26,317	–	–	0.67%	41
2016 Q1	$1.88M	Sell	26,317 -100	-0.4%	-$6.71K	0.6%	47
2015 Q4	$1.88M	Buy	+26,417	New	+$1.78M	0.62%	47

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

MWNA

Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Argent Trust's DGX Position: Q1 2018 in Review

Argent Trust reduced its Quest Diagnostics (DGX) stake by 0.12% in Q1 2018, selling an estimated $3.07K and leaving 24,923 shares worth $2.5M. The position accounts for 0.68% of the portfolio, ranked #45.

Argent Trust first reported a position in DGX in Q4 2015 and has held it in 10 quarters since. The position peaked at $2.78M in Q2 2017. 652 funds tracked by Wall St. Rank hold DGX as of Q1 2018.

Argent Trust held 24,923 shares of Quest Diagnostics worth $2.5M as of Q1 2018.
Argent Trust sold 30 Quest Diagnostics shares in Q1 2018, an estimated $3.07K.
Quest Diagnostics made up 0.68% of Argent Trust's portfolio in Q1 2018, its #45 holding.
Argent Trust first reported a position in Quest Diagnostics in Q4 2015 and has held it in 10 quarters since.
Argent Trust's Quest Diagnostics position peaked at $2.78M in Q2 2017.
652 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.